Caribou Biosciences

About:

Caribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology.

Website: http://www.cariboubio.com

Twitter/X: cariboubio

Top Investors: Mission BioCapital, Pfizer, AbbVie, Novartis, National Science Foundation

Description:

Caribou Biosciences is an operator of a medical technology company intended to analyze cell and genome engineering. The company specializes in cellular engineering and analysis based on the CRISPR-Cas9 technology platform which paired with a guide RNA, cuts double-stranded DNA and allows for specific changes to DNA, enabling the development of therapeutics for agricultural biotechnology, industrial biotechnology, and basic and applied biological research.